Public Company News

I-Mab Announces Senior Management Team Share Purchase Plan

SHANGHAI and GAITHERSBURG, MD., Jan. 6, 2022 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, today announced that the senior management team of the Company, includin...

2022-01-06 21:00 4217

Happiness Development Announces Financial Results for the Six Months Ended September 30, 2021

NANPING, China, Jan. 6, 2022 /PRNewswire/ -- Happiness Development Group Limited ("HAPP" or the "Company"), (NASDAQ: HAPP) aChina-based company engaging in the business of production of nutraceutical and dietary supplements, providing e-commerce sales and e-commerce marketing solutions, and the s...

2022-01-06 21:00 3988

Alterity Therapeutics Granted New US Patent for Compounds for Neurodegenerative Diseases Including Parkinson's and Alzheimer's

MELBOURNE, Australia and SAN FRANCISCO, Jan. 6, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced the United States Patent ...

2022-01-06 20:30 4165

Missfresh Signs 20+ Major Regional Grocery Store Chains To Use Its Retail Cloud Services

BEIJING, Jan. 6, 2022 /PRNewswire/ -- Missfresh Limited ("Missfresh" or the "Company") (NASDAQ: MF), an innovator inChina's neighborhood retail industry, has inked agreements with more than 20 regional supermarket chains to equip more than 150 stores in 19 cities inChi...

2022-01-06 19:30 2716

AKESO'S CADONILIMAB (PD-1/CTLA-4 BI-SPECIFIC ANTIBODY) COMBINED WITH IVONESCIMAB (PD-1/VEGF BI-SPECIFIC ANTIBODY) COMBINED WITH OR WITHOUT CHEMOTHERAPY OBTAINED APPROVAL TO INITIATE A PHASE Ib/II CLINICAL TRIAL FOR THE TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER

HONG KONG, Jan. 6, 2022 /PRNewswire/ -- Today, Akeso, Inc. (09926.HK) announces that Cadonilimab (PD-1/CTLA-4 bi-specific antibody), the  first-inclass novel immuno-oncology drug independently developed by the Company, combined with Ivonescimab (PD-1/VEGF bi-specific antibody), the novel immuno-o...

2022-01-06 19:00 2822

ReneSola Power Closes New Sale of Projects in Poland to Obton

STAMFORD, Conn., Jan. 6, 2022 /PRNewswire/ -- ReneSola Ltd. ("ReneSola Power" or "the Company") (www.renesolapower.com ) (NYSE: SOL), a leading fully integrated solar project developer, today announced that in December, 2021, The Company closed on the sale of 37 MW ...

2022-01-06 19:00 3585

Tuya Smart Introduces Tuya Cube at CES 2022

LAS VEGAS, Jan. 6, 2022 /PRNewswire/ -- Tuya Smart (NYSE: TUYA), a global IoT development platform service provider, unveiled an innovative new solution to the market at CES 2022: Tuya Cube. Tuya Cube offers everything developers need to build their own private IoT platforms with distinctive feat...

2022-01-06 17:50 3366

Dada Group Announces "No Close" During 2022 Chinese New Year

SHANGHAI, Jan. 6, 2022 /PRNewswire/ -- Dada Group (Nasdaq: DADA), China's leading local on-demand delivery and retail platform, today announced its Dada Now and JDDJ platforms, would stay open and continue to offer one-hour on-demand shopping service to consumers across the country during 2022 Ch...

2022-01-06 16:35 2461

Ascentage Pharma to Present at the J.P. Morgan 40th Annual Healthcare Conference

SUZHOU, China and ROCKVILLE, Md., Jan. 5, 2022 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced its participation in and presentation at the 40th A...

2022-01-06 08:30 7976

Hyundai Heavy Industries Group to Become "Future Builder" Beyond the World's Best Shipbuilder

LAS VEGAS, Jan. 5, 2022 /PRNewswire/ -- "Hyundai Heavy Industries Group has grown into the world's biggest shipbuilder for the past 50 years. Now, it will become a "Future Builder," creating new values for humankind." Kisun Chung, CEO of Hyund...

2022-01-06 06:07 2650

Top Pet Goods Retailer to Expand Availability of Dogness Smart Pet Products in Stores and Online

PLANO, Texas, Jan. 5, 2022 /PRNewswire/ -- Dogness (International) Corporation ("Dogness" or the "Company") (NASDAQ: DOGZ), a developer and manufacturer of a comprehensive line of Dogness-branded, OEM and private label pet products, today announced a top pet goods retailer will be expanding avail...

2022-01-05 22:00 2146

Johnson Matthey launches HyCOgen, an enabling technology to efficiently convert CO2 and green hydrogen into sustainable aviation fuel

- Launch of HyCOgen will play a key role in enabling captured CO2 and green hydrogen to be converted into sustainable aviation fuel - In combination with FT CANSTM technology, Johnson Matthey delivers an integrated, scalable solution LONDON, Jan. 5, 2022 /PRNewswire/ -- Johnson Matthey, a global...

2022-01-05 21:25 2802

Dunxin Financial Holdings Limited Announces Results of 2021 Annual General Meeting of Shareholders

WUHAN, China, Jan. 5, 2022 /PRNewswire/ -- Dunxin Financial Holdings Limited ("Dunxin" or the "Company") (NYSE American: DXF), a licensed microfinance lender serving individuals and small and medium enterprises ("SMEs") inHubei Province, China, today announced the results of its 2021 annual gener...

2022-01-05 21:00 4031

Alterity Therapeutics to Present at the H.C. Wainwright BIOCONNECT Virtual Conference

MELBOURNE, Australia, Jan. 5, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced thatDavid Stamler, M.D., Chief Executive Of...

2022-01-05 20:45 4053

IMTE raise funds to support the acquisition and building out of manufacturing infrastructure

SYDNEY, Jan. 5, 2022 /PRNewswire/ -- Integrated Media Technology Limited ("IMTE" or "Company") (Nasdaq:IMTE), informs that the Company raise funds to support the acquisition and building out of manufacturing infrastructure.  On January 3, 2022, the Company entered into convertible note purchase...

2022-01-05 20:44 4130

Recurrent Energy Signs Agreement to Sell 150 MWac Virginia Solar Project to Appalachian Power

GUELPH, Ontario, Jan. 5, 2022 /PRNewswire/ --  Canadian Solar Inc.  ("Canadian Solar") (NASDAQ: CSIQ) today announced its wholly-owned subsidiary,Recurrent Energy, LLC  ("Recurrent"), has completed a purchase and sale agreement with Ap...

2022-01-05 20:00 3188

TuanChe Announces Plan to Strategically Expand into Electric Vehicle Manufacturing Sector

BEIJING, Jan. 5, 2022 /PRNewswire/ -- TuanChe Limited ("TuanChe" or the "Company ") (NASDAQ: TC), a leading integrated automotive marketplace inChina, today announced its strategic plan to establish a new electric vehicle (EV) business line including a design, R&D and manufacturing team and expand...

2022-01-05 19:00 3856

Coway Unveils New Smart Home Solutions at CES 2022

* Coway introduces its Smart Care Air Mattress and Smart Sleep Solution, combining its latest Sleep and Air Care innovation, for the first time with an interactive experience exclusively at the booth * Exhibit also features new "Noble Collection," highlighting Coway's impressive product desig...

2022-01-05 13:02 2862

Bairong Inc. Named in KPMG's China Fintech 50 List for Sixth Consecutive Year

BEIJING, Jan. 4, 2022 /PRNewswire/ -- Bairong Inc. ("Bairong" or "the Company", 6608.HK), a leading independent AI-powered technology platform inChina, has been named in KPMG China's 2021 China Fintech 50 list for the sixth consecutive year. It is also one of the few companies to earn accolades i...

2022-01-05 11:15 4515

Doosan Robotics' collaborative robots marks annual sales of over 1,000 units, breaking through domestic records

* Acquires investment worth US$33.7 million from Praxis Capital Partners & Korea Investment Partners * Plans to establish North America and Europe subsidiaries, aiming to expand global market footprint * Aims for IPO in the future while strengthening R&D capability to increase global market...

2022-01-05 01:00 2509
1 ... 675676677678679680681 ... 762